NEW YORK, March 9, 2017 /PRNewswire/ --
Stock-Callers.com have issued research reports on four Services equities,and they are Patterson Cos. Inc. (NASDAQ: PDCO), Owens & Minor Inc. (NYSE: OMI), Henry Schein Inc. (NASDAQ: HSIC), and CEB Inc. (NYSE: CEB). According to industry data released on March 03rd,
St. Paul, Minnesota headquartered Patterson Cos. Inc.'s stock finished Wednesday's session 0.50% higher at $44.37, with a total trading volume of 958,854 shares. Over the last month and the previous three months, the Company's shares have advanced 5.37% and 12.66%, respectively. Additionally, the stock has gained 8.77% since the start of this year. Shares of the Company are trading above their 50-day moving average by 4.46%. Moreover, shares of Patterson Cos., which distributes and sells dental and animal health products in the US, the UK, and Canada, have a Relative Strength Index (RSI) of 54.65.
On February 23rd, 2017, Patterson reported consolidated net sales of $1.4 in Q3 FY17, down 0.2% on a y-o-y basis. Adjusting for the effects of currency translation, sales improved 1.4%. The Company reported net income from continuing operations was $27.8 million, or $0.29 per diluted share, for Q3 FY17 compared to $57.2 million, or $0.60 per diluted share, in Q3 FY16. Your complete research report on PDCO can be retrieved for free at:
Owens & Minor
Shares in Mechanicsville, Virginia headquartered Owens & Minor Inc. climbed 0.51%, ending yesterday's session at $35.72, with a total trading volume of 444,748 shares. The stock has gained 5.30% in the previous three months and 1.22% on an YTD basis. The Company's shares are trading 2.48% above their 200-day moving average. Moreover, shares of Owens & Minor, which together with its subsidiaries, operates as a healthcare services company in the US, the UK, Ireland, France, Germany, and other European countries, have an RSI of 46.85.
On February 16th, 2017, Governor Terry McAuliffe announced that Virginia-based Owens & Minor, a global healthcare services company, will make a multi-year, multi-million dollar investment to establish a new Client Engagement Center (CEC) in downtown Richmond. Owens & Minor's CEC will occupy approximately 90,000 square feet at Riverfront Plaza. The state of the art CEC facility will house approximately 500 teammates, including the addition of 300 newly created positions. A free report on OMI is just a click away at:
On Wednesday, Melville, New York headquartered Henry Schein Inc.'s stock saw a slight decline of 0.10%, to close the day at $170.89. A total volume of 359,439 shares was traded. The Company's shares have advanced 5.10% in the last one month, 13.97% in the previous three months, and 12.64% on an YTD basis. The stock is trading 5.44% and 4.27% above its 50-day and 200-day moving averages, respectively. Additionally, shares of Henry Schein, which provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide, have an RSI of 63.16.
On February 22nd, 2017, research firm Barrington Research reiterated its 'Outperform' rating on the Company's stock with an increase of the target price from $185 a share to $196 a share.
On February 23rd, 2017, Henry Schein announced the launch of its newly designed website, http://www.henryschein.com, which features new content and enhanced functionality built to deliver a greater customer experience. With a refreshed, contemporary look and feel, the new site includes a wide range of enhancements, including better navigation and search capability to help customers efficiently maneuver through the wide selection of branded and Henry Schein private-brand products, and gain easy access to the many other technologies, clinical, business, and supply chain solutions featured on the site. Sign up for your complimentary research report on HSIC at:
Shares in Arlington, Virginia headquartered CEB Inc. ended the day 0.52% higher at $77.95, with a total trading volume of 334,490 shares. The stock has gained 2.04% in the last one month, 36.28% in the previous three months, and 28.63% since the start of this year. The Company's shares are trading above their 50-day and 200-day moving averages by 4.96% and 26.02%, respectively. Furthermore, shares of CEB, which operates as a practice insight and technology company in the US, Europe, and internationally, have an RSI of 63.05.
On February 13th, 2017, research firm SunTrust downgraded the Company's stock rating from 'Buy' to 'Hold'. Register for free on Stock-Callers.com and download the latest research report on CEB at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email firstname.lastname@example.org. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: email@example.com Phone number: +44 330 808 3765 Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA
Subscribe to our Free Newsletters!
The Hib vaccine protects children against infections like meningitis and pneumonia that are caused ...
Dysthymia or persistent depressive disorder (PDD) is a chronic low mood and self-esteem affecting ...
Vitamin A is an extremely vital vitamin needed for the eyes, skin, hair, immunity and during ...View All